The Holgos Comprehensive Insurance Zone added the "new" production line!

Tianshan News (Reporter Basha Tiegus) On June 18, in the Holgos Comprehensive Free Trade Zone in Hollys, Ili Kazakh, pure Chinese medicine preparation uremia clear particles fully automatic production line trial production.

Urexia clear particles are the main varieties of Kangchen Pharmaceutical Group, a listed company in Hong Kong. The uremia clear particles are not only the first modern Chinese medicines in the field of chronic kidney disease to adopt international top -level evidence -based research, but also the first to be by the Ministry of Health of the Ministry of National Health. A pure Chinese medicine preparation approved for the treatment of chronic renal failure (CRF) fills the market gap in the treatment of chronic renal failure in the treatment of chronic renal failure.

On June 18th, in the Holgos Comprehensive Free Trade Zone in Hollys, Ili, the treatment line of the pure traditional Chinese medicine preparation of chronic renal failure (CRF) was trial. Pomegranate cloud/Xinjiang Daily reporter Basha Tiegus Photo

Kangchen Pharmaceutical Group is a high -tech pharmaceutical company focusing on the research and development, production and sales of Chinese medicine and chemical medicines. In the bonded zone, the total investment is 1 billion yuan, the construction area of ​​the plant is 27,000 square meters, the annual output is expected to be about 100,000 pieces, and the total annual income will be more than 1.5 billion yuan, which will directly drive nearly a thousand people.

A few days ago, the "Promoting High -quality Integration of Traditional Chinese Medicine Integration into the" Belt and Road "Development Plan (2021-2025)" issued by the State Administration of Traditional Chinese Medicine proposed that during the "14th Five -Year Plan" period, my country will build the "Belt and Road" country with the "Belt and Road" country. Cooperate with 30 high -quality Chinese medicine overseas centers and provide high -quality Chinese medicine services to the people of the "Belt and Road" countries.

Horgos' unique geographical advantages and "five exemptions and five reductions" policy advantages, and a good business environment is the greatest attraction of Kangchen Pharmaceutical's choice of creating a new production base in Holgos. "The completion of the Kangchen Pharmaceutical Holgos Base helps it to make full use of the advantages of the rich Chinese herbal medicine resources of the northwest, especially the Yili River Valley, and the" Belt and Road "countries along the line, and vigorously develop the potential market of patients with kidney disease in the five countries of Central Asia. Help Chinese medicine to the world stage. "Chen Lianhui, chairman of Kangchen Pharmaceutical (Holgos) Co., Ltd. said.

In recent years, Horgos City has actively integrated into the national "Belt and Road" construction process, giving full play to the advantages of "location, policies, and opening up", adhering to the development of the real economy as the core, and promoting the China Holgos International Border Cooperation Center and The construction of the integrated bonded zone is a breakthrough, with the "one district and three parks" of the Horgos Economic Development Zone as the carrier, and the development of "two Huo, two Iraqi" is an important support. Reform and opening up, a large number of key projects with high -tech and high output value have been implemented one after another, showing a good situation of large construction, opening up, and big development.

- END -